TH
APGE icon

Transmarket Holdings’s Apogee Therapeutics APGE Stock Holding History

Transmarket Holdings’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
+34,493
New +$3.11M 3.36% 16

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Transmarket Holdings's APGE Position: Q2 2026 in Review

Transmarket Holdings opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 34,493 shares worth $4.58M. The stake represents 3.36% of the portfolio and ranks #16 among its holdings.

14 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Transmarket Holdings held 34,493 shares of Apogee Therapeutics worth $4.58M as of Q2 2026.
  • Apogee Therapeutics was a new Transmarket Holdings position in Q2 2026.
  • Apogee Therapeutics made up 3.36% of Transmarket Holdings's portfolio in Q2 2026, its #16 holding.
  • 14 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Transmarket Holdings's 13F filing for Q2 2026, filed 21 Jul 2026.